ZYNERBA PHARMACEUTICALS : Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel in Fragile X Syndrome

Press/Media: Press / Media

PeriodJul 1 2020

Media coverage

2

Media coverage